DIRECTOR OF BIOPHARMACEUTICAL TECHNOLOGY INNOVATION & OPTIMIZATION CENTER
University of Kansas
Michael J. Hageman, Valentino J. Stella Distinguished Professor Pharmaceutical Chemistry, University of Kansas, He has 30+ years of experience in the pharmaceutical industry, including Upjohn, Pharmacia, Pfizer and Executive Director at Bristol-Myers Squibb. He obtained his BS in Pharmacy and PhD in Pharmaceutical Chemistry from the University of Kansas. He recently joined Pharmaceutical Chemistry Dept. and is the Director for the Biopharmaceutical Innovation and Optimization Center. https://biocenter.ku.edu/ His labs focus on Physical Pharmacy and Drug Delivery (P2D2) for oral delivery of poorly soluble and poorly permeable drugs, including the stabilization, formulation and processing of peptides and proteins. While in industry, he worked in Discovery on design and selection of developable small drug-like molecules, peptides and protein biologics. Significant emphasis was placed on providing physicochemical property characterization, including the design of preclinical dosage forms for enhanced bioavailability to provide successful progression of the drug candidates, yet have a clear line-of-sight to a product dosage form. He was previously an adjunct professor at the Universities of Purdue, Kansas, and Utah. He is an editor for JPharmSci and chairs the Drug Delivery Advisory Committee for PhRMA Foundation. He is an AAPS Fellow and served as Chair of AAPS Physical Pharmacy and Biopharmaceutics Section.